Skip to main content
. 2022 Nov 3;6(4):e354–e364. doi: 10.1055/s-0042-1757744

Fig. 1.

Fig. 1

Treatment patterns over 12-months follow-up. No OAC includes end of study from death, termination of treatment or loss to follow-up. DOAC, direct oral anticoagulant; OAC, oral anticoagulant; VKA, vitamin-K antagonist.